OnKure Therapeutics (OKUR) Institutional Ownership $5.46 0.00 (0.00%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.44 -0.01 (-0.27%) As of 02/21/2025 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for OnKure Therapeutics (NASDAQ:OKUR)CurrentInstitutional OwnershipPercentage90.98%Number ofInstitutional Buyers(last 12 months)31TotalInstitutional Inflows(last 12 months)$63.98MNumber ofInstitutional Sellers(last 12 months)0 Get OKUR Insider Trade Alerts Want to know when executives and insiders are buying or selling OnKure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OKUR Institutional Buying and Selling by Quarter OnKure Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Vestal Point Capital LP635,000$5.46M0.3%N/A19.012% 2/17/2025 Two Sigma Advisers LP14,228$122K0.0%N/A0.426% 2/17/2025 Tang Capital Management LLC294,626$2.53M0.2%N/A8.821% 2/17/2025 Shay Capital LLC15,016$129K0.0%N/A0.450% 2/17/2025 Sphera Funds Management LTD.87,354$751K0.1%N/A2.615% 2/17/2025 Prosight Management LP63,754$548K0.2%N/A1.909% 2/17/2025 OMERS ADMINISTRATION Corp12,100$104K0.0%N/A0.362% 2/17/2025 NEA Management Company LLC478,548$4.12M0.2%N/A14.328% 2/17/2025 Millennium Management LLC144,099$1.24M0.0%N/A4.314% 2/17/2025 Deep Track Capital LP523,989$4.51M0.2%N/A15.688% Get the Latest News and Ratings for OKUR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OnKure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Cubist Systematic Strategies LLC20,549$177K0.0%N/A0.615% 2/17/2025 Cantor Fitzgerald L. P.35,700$294K0.0%N/A1.069% 2/17/2025 Citadel Advisors LLC1,074,314$8.78M0.0%N/A32.165% 2/17/2025 Bank of America Corp DE249,642$2.15M0.0%N/A7.474% 2/17/2025 683 Capital Management LLC43,371$373K0.0%N/A1.299% 2/17/2025 Acorn Capital Advisors LLC1,439,674$12.38M6.8%N/A43.104% 2/14/2025 Samsara BioCapital LLC824,155$7.09M1.0%N/A24.675% 2/14/2025 Nantahala Capital Management LLC54,777$471K0.0%N/A1.640% 2/14/2025 Northern Trust Corp19,177$165K0.0%N/A0.574% 2/14/2025 Boothbay Fund Management LLC78,021$671K0.0%N/A2.336% 2/14/2025 Altium Capital Management LLC218,386$1.88M0.5%N/A6.539% 2/13/2025 Affinity Asset Advisors LLC144,159$1.24M0.2%N/A4.316% 2/13/2025 Carlyle Group Inc.269,895$2.33M0.5%N/A8.081% 2/13/2025 Walleye Capital LLC13,495$116K0.0%N/A0.404% 2/13/2025 XTX Topco Ltd18,633$160K0.0%N/A0.558% 2/13/2025 Barclays PLC8,741$75K0.0%N/A0.262% 2/13/2025 Renaissance Technologies LLC47,450$408K0.0%N/A1.421% 2/12/2025 Aldebaran Capital LLC45,572$392K0.4%N/A1.363% 2/12/2025 Aisling Capital Management LP88,607$762K0.3%N/A2.651% 2/12/2025 Geode Capital Management LLC76,599$659K0.0%N/A2.291% 2/12/2025 Highbridge Capital Management LLC399,743$3.44M0.1%N/A11.958% (Data available from 1/1/2016 forward) OKUR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OKUR shares? During the previous two years, 31 institutional investors and hedge funds held shares of OnKure Therapeutics. The most heavily invested institutionals were Acorn Capital Advisors LLC ($12.38M), Citadel Advisors LLC ($8.78M), Samsara BioCapital LLC ($7.09M), Vestal Point Capital LP ($5.46M), Deep Track Capital LP ($4.51M), NEA Management Company LLC ($4.12M), and Highbridge Capital Management LLC ($3.44M).Learn more on OKUR's institutional investors. What percentage of OnKure Therapeutics stock is owned by institutional investors? 90.98% of OnKure Therapeutics stock is owned by institutional investors. Learn more on OKUR's institutional investor holdings. Which institutional investors have been buying OnKure Therapeutics stock? Of the 31 institutional investors that purchased OnKure Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acorn Capital Advisors LLC ($1.44M), Citadel Advisors LLC ($1.07M), Samsara BioCapital LLC ($824.16K), Vestal Point Capital LP ($635K), Deep Track Capital LP ($523.99K), NEA Management Company LLC ($478.55K), and Highbridge Capital Management LLC ($399.74K). How much institutional buying is happening at OnKure Therapeutics? Institutional investors have bought a total of 7,439,374 shares in the last 24 months. This purchase volume represents approximately $63.98M in transactions. Related Companies Forte Biosciences Major Shareholders Avalo Therapeutics Major Shareholders Applied Therapeutics Major Shareholders InterCure Major Shareholders Mural Oncology Major Shareholders Gain Therapeutics Major Shareholders PMV Pharmaceuticals Major Shareholders Ikena Oncology Major Shareholders Mersana Therapeutics Major Shareholders Aerovate Therapeutics Major Shareholders This page (NASDAQ:OKUR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OnKure Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share OnKure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OKUR Stock Alerts